Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | KNSA |
---|---|---|
09:32 ET | 6972 | 18.71 |
09:34 ET | 4462 | 18.61 |
09:38 ET | 346 | 18.72 |
09:39 ET | 100 | 18.705 |
09:41 ET | 797 | 18.7807 |
09:45 ET | 768 | 18.87 |
09:48 ET | 800 | 18.86 |
09:50 ET | 612 | 18.85 |
09:52 ET | 334 | 18.84 |
09:56 ET | 897 | 18.83 |
09:59 ET | 200 | 18.88 |
10:01 ET | 321 | 18.89 |
10:06 ET | 554 | 18.83 |
10:08 ET | 400 | 18.81 |
10:10 ET | 1120 | 18.835 |
10:12 ET | 1000 | 18.78 |
10:14 ET | 1595 | 18.82 |
10:15 ET | 3100 | 18.85 |
10:17 ET | 920 | 18.855 |
10:19 ET | 100 | 18.855 |
10:24 ET | 1100 | 18.89 |
10:26 ET | 300 | 18.91 |
10:32 ET | 300 | 18.9 |
10:33 ET | 186 | 18.935 |
10:35 ET | 200 | 18.96 |
10:46 ET | 1300 | 18.97 |
10:51 ET | 200 | 18.965 |
10:53 ET | 100 | 18.94 |
10:57 ET | 100 | 18.95 |
11:00 ET | 100 | 18.92 |
11:06 ET | 100 | 18.905 |
11:08 ET | 100 | 18.905 |
11:09 ET | 200 | 18.93 |
11:13 ET | 400 | 18.925 |
11:18 ET | 600 | 18.97 |
11:20 ET | 168 | 18.99 |
11:22 ET | 100 | 18.95 |
11:27 ET | 799 | 18.95 |
11:31 ET | 300 | 18.97 |
11:33 ET | 200 | 18.985 |
11:40 ET | 200 | 18.97 |
11:42 ET | 1000 | 18.9865 |
11:44 ET | 500 | 18.9686 |
11:45 ET | 100 | 18.99 |
11:47 ET | 100 | 18.99 |
11:49 ET | 500 | 19 |
11:54 ET | 100 | 19.02 |
11:56 ET | 100 | 19.02 |
11:58 ET | 500 | 19.03 |
12:00 ET | 500 | 19.03 |
12:02 ET | 100 | 19.025 |
12:03 ET | 410 | 19.035 |
12:07 ET | 400 | 19.01 |
12:09 ET | 128 | 18.96 |
12:12 ET | 596 | 18.94 |
12:14 ET | 117 | 18.91 |
12:16 ET | 129 | 18.9 |
12:18 ET | 310 | 18.92 |
12:20 ET | 100 | 18.945 |
12:27 ET | 200 | 18.96 |
12:34 ET | 229 | 18.94 |
12:38 ET | 100 | 18.95 |
12:39 ET | 100 | 18.95 |
12:41 ET | 200 | 18.95 |
12:45 ET | 100 | 18.9 |
12:48 ET | 642 | 18.9 |
12:50 ET | 100 | 18.87 |
12:52 ET | 100 | 18.87 |
12:54 ET | 1200 | 18.8825 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Kiniksa Pharmaceuticals Ltd | 1.4B | 221.6x | --- |
Ginkgo Bioworks Holdings Inc | 1.2B | -1.1x | --- |
BioCryst Pharmaceuticals Inc | 1.3B | -5.9x | --- |
Dynavax Technologies Corp | 1.6B | 235.7x | --- |
Zai Lab Ltd | 1.9B | -5.7x | --- |
MannKind Corp | 1.3B | 190.1x | --- |
Kiniksa Pharmaceuticals, Ltd. is a biopharmaceutical company. The Company is focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its portfolio of immune-modulating assets, ARCALYST (rilonacept), KPL-404 and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. The Company’s ARCALYST is interleukin-1alpha (IL-1α), and interleukin-1beta (IL-1β), cytokine trap for the treatment of recurrent pericarditis and reduction in risk of recurrence in adults and children. Its KPL-404 is an investigational monoclonal antibody inhibitor of CD40-CD154 interaction. The Company’s Mavrilimumab is an investigational monoclonal antibody inhibitor targeting granulocyte-macrophage colony stimulating factor receptor alpha (GM-CSFRα).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
---|---|
Revenue (TTM) | $301.8M |
Shares Outstanding | 70.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.38 |
EPS | $0.09 |
Book Value | $6.23 |
P/E Ratio | 221.6x |
Price/Sales (TTM) | 4.6 |
Price/Cash Flow (TTM) | 127.5x |
Operating Margin | -10.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.